The clinical utility of CK-MB measurement in patients suspected of acute coronary syndrome

Jaehyup Kim, Ibrahim A. Hashim

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: This study aims to assess the clinical utility of CK-MB measurement in patients suspected of acute coronary syndrome (ACS). Methods: All CK-MB and troponin T measurements performed <1 h apart during the study period were obtained and analyzed for concordance. A total of 1214 cases with discordant biomarkers results were found. Retrospective review of electronic health records (EHRs) was performed to assess the clinical impact, if any, of the discordant biomarkers results. Results: In 401 cases, CK-MB concentrations were increased whereas troponin T concentrations were negative at <0.01 ng/ml. In this group, clinical interpretations included, rhabdomyolysis, demand ischemia, and drug intoxication. No additional investigations for ACS were conducted in this group. Among the remaining 813 cases, troponin T concentrations were increased in the presence of a normal CK-MB result. In this group, the discordant normal CK-MB lowered suspicion for ACS in only 22 cases (2.7%). Most common interpretations for isolated positive troponin were demand ischemia and impaired renal function. In most cases, discordant CK-MB results were not considered a significant finding. Conclusions: In the setting of suspected ACS, CK-MB has limited clinical impact when contemporary troponin assay results are available.

Original languageEnglish (US)
Pages (from-to)89-92
Number of pages4
JournalClinica Chimica Acta
Volume456
DOIs
StatePublished - May 1 2016

Fingerprint

Troponin T
Acute Coronary Syndrome
Troponin
Biomarkers
Ischemia
Rhabdomyolysis
Electronic Health Records
Assays
Health
Kidney
Pharmaceutical Preparations

Keywords

  • Acute coronary syndrome
  • Creatine kinase
  • Troponin

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

The clinical utility of CK-MB measurement in patients suspected of acute coronary syndrome. / Kim, Jaehyup; Hashim, Ibrahim A.

In: Clinica Chimica Acta, Vol. 456, 01.05.2016, p. 89-92.

Research output: Contribution to journalArticle

@article{90ca91bded84459fbf33c96f0f8d1905,
title = "The clinical utility of CK-MB measurement in patients suspected of acute coronary syndrome",
abstract = "Background: This study aims to assess the clinical utility of CK-MB measurement in patients suspected of acute coronary syndrome (ACS). Methods: All CK-MB and troponin T measurements performed <1 h apart during the study period were obtained and analyzed for concordance. A total of 1214 cases with discordant biomarkers results were found. Retrospective review of electronic health records (EHRs) was performed to assess the clinical impact, if any, of the discordant biomarkers results. Results: In 401 cases, CK-MB concentrations were increased whereas troponin T concentrations were negative at <0.01 ng/ml. In this group, clinical interpretations included, rhabdomyolysis, demand ischemia, and drug intoxication. No additional investigations for ACS were conducted in this group. Among the remaining 813 cases, troponin T concentrations were increased in the presence of a normal CK-MB result. In this group, the discordant normal CK-MB lowered suspicion for ACS in only 22 cases (2.7{\%}). Most common interpretations for isolated positive troponin were demand ischemia and impaired renal function. In most cases, discordant CK-MB results were not considered a significant finding. Conclusions: In the setting of suspected ACS, CK-MB has limited clinical impact when contemporary troponin assay results are available.",
keywords = "Acute coronary syndrome, Creatine kinase, Troponin",
author = "Jaehyup Kim and Hashim, {Ibrahim A.}",
year = "2016",
month = "5",
day = "1",
doi = "10.1016/j.cca.2016.02.030",
language = "English (US)",
volume = "456",
pages = "89--92",
journal = "Clinica Chimica Acta",
issn = "0009-8981",
publisher = "Elsevier",

}

TY - JOUR

T1 - The clinical utility of CK-MB measurement in patients suspected of acute coronary syndrome

AU - Kim, Jaehyup

AU - Hashim, Ibrahim A.

PY - 2016/5/1

Y1 - 2016/5/1

N2 - Background: This study aims to assess the clinical utility of CK-MB measurement in patients suspected of acute coronary syndrome (ACS). Methods: All CK-MB and troponin T measurements performed <1 h apart during the study period were obtained and analyzed for concordance. A total of 1214 cases with discordant biomarkers results were found. Retrospective review of electronic health records (EHRs) was performed to assess the clinical impact, if any, of the discordant biomarkers results. Results: In 401 cases, CK-MB concentrations were increased whereas troponin T concentrations were negative at <0.01 ng/ml. In this group, clinical interpretations included, rhabdomyolysis, demand ischemia, and drug intoxication. No additional investigations for ACS were conducted in this group. Among the remaining 813 cases, troponin T concentrations were increased in the presence of a normal CK-MB result. In this group, the discordant normal CK-MB lowered suspicion for ACS in only 22 cases (2.7%). Most common interpretations for isolated positive troponin were demand ischemia and impaired renal function. In most cases, discordant CK-MB results were not considered a significant finding. Conclusions: In the setting of suspected ACS, CK-MB has limited clinical impact when contemporary troponin assay results are available.

AB - Background: This study aims to assess the clinical utility of CK-MB measurement in patients suspected of acute coronary syndrome (ACS). Methods: All CK-MB and troponin T measurements performed <1 h apart during the study period were obtained and analyzed for concordance. A total of 1214 cases with discordant biomarkers results were found. Retrospective review of electronic health records (EHRs) was performed to assess the clinical impact, if any, of the discordant biomarkers results. Results: In 401 cases, CK-MB concentrations were increased whereas troponin T concentrations were negative at <0.01 ng/ml. In this group, clinical interpretations included, rhabdomyolysis, demand ischemia, and drug intoxication. No additional investigations for ACS were conducted in this group. Among the remaining 813 cases, troponin T concentrations were increased in the presence of a normal CK-MB result. In this group, the discordant normal CK-MB lowered suspicion for ACS in only 22 cases (2.7%). Most common interpretations for isolated positive troponin were demand ischemia and impaired renal function. In most cases, discordant CK-MB results were not considered a significant finding. Conclusions: In the setting of suspected ACS, CK-MB has limited clinical impact when contemporary troponin assay results are available.

KW - Acute coronary syndrome

KW - Creatine kinase

KW - Troponin

UR - http://www.scopus.com/inward/record.url?scp=84960092530&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960092530&partnerID=8YFLogxK

U2 - 10.1016/j.cca.2016.02.030

DO - 10.1016/j.cca.2016.02.030

M3 - Article

C2 - 26945601

AN - SCOPUS:84960092530

VL - 456

SP - 89

EP - 92

JO - Clinica Chimica Acta

JF - Clinica Chimica Acta

SN - 0009-8981

ER -